Start with primary evidence
For medical and access claims we prioritise regulators, NHS bodies, health-technology organisations, trial registries and original research. Manufacturer announcements can provide timely information, but we identify company-reported results and do not present them as an independent clinical review.
Separate four decisions
Research findings, regulatory authorisation, actual supply and NHS funding are reported separately. A development overseas is not described as UK access. Where the four UK nations differ, we name the jurisdiction rather than treating England’s policy as a UK-wide rule.
Use dates that mean something
News articles display both publication dates and the date of the event or evidence discussed. Country pages give a source-check date. Prices retain their observation date when a saved snapshot is used. A date is not a promise that a rule or price cannot have changed since.
Write original explanations
We write our own explanations of what evidence supports and what it leaves open. We do not reproduce press releases as articles or create testimonial stories. Software may assist research organisation and drafting; source links and clear qualifications remain part of the published work.
Be honest about review
The editorial-team byline identifies the publisher’s content function. These launch articles have not been represented as independently clinician-reviewed. We do not display invented medical reviewers, qualifications or trust seals. General information should be discussed with a clinician when making personal treatment decisions.
Correct meaningful errors
A correction request should identify the page, disputed wording or price, a reliable source and the date observed. We assess factual corrections separately from requests to improve a provider’s ranking. The contact page gives the publisher’s correspondence address.
Written for a UK audience by the Health Comparisons editorial team. This page is an information resource and has not been presented as a clinician’s personal recommendation. Discuss treatment decisions with your prescriber.
Read our editorial standards →